Hyophen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Star Pharmaceuticals, Llc. The primary component is Methenamine; Benzoic Acid; Phenyl Salicylate; Methylene Blue; Hyoscyamine Sulfate.
Product ID | 0076-0901_45640779-4ba0-45fd-e054-00144ff88e88 |
NDC | 0076-0901 |
Product Type | Human Prescription Drug |
Proprietary Name | Hyophen |
Generic Name | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2010-09-21 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Star Pharmaceuticals, LLC |
Substance Name | METHENAMINE; BENZOIC ACID; PHENYL SALICYLATE; METHYLENE BLUE; HYOSCYAMINE SULFATE |
Active Ingredient Strength | 82 mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharm Classes | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2010-09-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-09-21 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
METHENAMINE | 81.6 mg/1 |
SPL SET ID: | 2c1f0f4c-e57b-4df5-9a58-41d39c3d8893 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0076-0901 | Hyophen | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
44523-741 | Hyophen | Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HYOPHEN 85472508 4167986 Live/Registered |
BIOCOMP PHARMA, INC. 2011-11-15 |